Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Jun;235(6):863-71.
doi: 10.1097/00000658-200206000-00015.

Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis

Affiliations
Review

Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis

Henrik Petrowsky et al. Ann Surg. 2002 Jun.

Abstract

Objective: To determine the value of repeat liver resection for recurrent colorectal metastases to the liver.

Summary background data: Liver resection represents the best and a potentially curative treatment for metastatic colorectal cancer to the liver. After resection, however, most patients develop recurrent disease, often isolated to the liver.

Methods: This study reports the combined experience of repeat liver resection for recurrent liver metastases at an American and a European surgical oncology center. Patients were identified from prospective databases and records were retrospectively reviewed. A total of 126 patients (American n = 96, 1986-2001; European n = 30, 1985-1999) underwent repeat liver resection. Patient characteristics were similar in the two institutions. Median follow-up from first liver resection was 88 and 105 months, respectively.

Results: Operations performed included 90 minor resections and 36 resections of a lobe or more. The 1-, 3-, and 5-year survival rates were 86%, 51%, and 34%. There were 19 actual 5-year survivors to date. By multivariate regression analysis (proportional hazard model), more than one lesion and tumor size larger than 5 cm were independent prognostic indicators of reduced survival. The interval between the first and second liver resection was not predictive of outcome.

Conclusions: Repeat liver resection for colorectal liver metastases is safe. Patients with a low tumor load are the best candidates for a repeat resection. In well-selected patients, further resection of the liver can provide prolonged survival after recurrence of colorectal liver metastases.

PubMed Disclaimer

Figures

None
Figure 1. Kaplan-Meier plots: Cumulative survival after second liver resection for: (A) the entire study population, (B) number of hepatic lesions = 1 (plot 1) and more than 1 (plot 2), (Continues)
None
Figure 1. Continued. (C) size of the largest lesion less than 5 cm (plot 1) and more than 5 cm (plot 2), and (D) the subpopulations (number = 1, size < 5: plot 1), (number = 1, size > 5: plot 2), (number > 1, size < 5, plot 3), (number > 1, size > 5, plot 4).

References

    1. Gilbert HA, Kagan AR. Metastases: incidence, detection, and evaluation without histologic confirmation. In Weiss L, ed. Fundamental aspects of metastasis. Amsterdam: North-Holland, 1976: 385–405.
    1. Jaffe BM, Donegan WL, Watson F, et al. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968; 127: 1–11. - PubMed
    1. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. Cancer 1969; 23: 198–202. - PubMed
    1. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685–693. - PMC - PubMed
    1. Cunningham D, Pyrhonen S, James RD, et al. Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998; 352: 1413–1418. - PubMed

MeSH terms